Skip to main content
TipRanks
Go Ultimate75% OFF

Genmab A/S (0MGB) Financial Statements

16 Followers

Genmab A/S Financial Overview

Genmab A/S's market cap is currently kr206.64B. The company's EPS TTM is kr11.88; its P/E ratio is 42.80; Genmab A/S is estimated to report earnings on February 24, 2027, and the estimated EPS forecast is kr15.11. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 3.86Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.48B
Gross Profitkr 3.54Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.48B
Operating Incomekr 1.30Bkr 7.00Bkr 5.32Bkr 6.30Bkr 2.95B
EBITDAkr 1.37Bkr 9.70Bkr 5.99Bkr 7.33Bkr 3.27B
Net Incomekr 999.19Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Balance Sheet
Cash & Short-Term Investmentskr 1.71Bkr 21.10Bkr 28.14Bkr 22.32Bkr 19.34B
Total Assetskr 12.84Bkr 45.81Bkr 35.29Bkr 30.12Bkr 24.63B
Total Debtkr 5.55Bkr 1.03Bkr 770.00Mkr 597.00Mkr 425.00M
Net Debtkr 3.84Bkr -8.83Bkr -14.10Bkr -9.30Bkr -8.53B
Total Liabilitieskr 7.01Bkr 9.11Bkr 3.68Bkr 2.84Bkr 2.43B
Stockholders' Equitykr 5.83Bkr 36.70Bkr 31.61Bkr 27.28Bkr 22.20B
Cash Flow
Free Cash Flowkr 1.19Bkr 7.58Bkr 7.00Bkr 3.60Bkr 1.98B
Operating Cash Flowkr 1.23Bkr 7.77Bkr 7.38Bkr 3.91Bkr 2.23B
Investing Cash Flowkr -5.86Bkr -9.91Bkr -1.28Bkr -2.76Bkr -961.00M
Financing Cash Flowkr 4.97Bkr -3.92Bkr -606.00Mkr -789.00Mkr -420.00M

Currency in DKK

Genmab A/S Earnings and Revenue History

08B16B24B20 %30 %40 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Genmab A/S Liabilities to Assets

020B40B60B0 %20 %40 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Genmab A/S Cash Flow

-15B-10B-5B05B10B201720182019202020212022202320242025OperatingInvestingFinancing

Genmab A/S Forecast EPS vs Actual EPS

-1001020304050Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss